Invus, L.P., Director, 10% Owner at LEXICON PHARMACEUTICALS, INC. (LXRX), bought 1,151,892 shares at $9.74 ($11.1M) on 2017-11-10, disclosed to the SEC on 2017-11-14.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.74 | 145,680 | $1.4M | 12.8% |
| 2 | $9.74 | 145,680 | $1.4M | 12.8% |
| 3 | $9.75 | 215,133 | $2.1M | 18.9% |
| 4 | $9.75 | 215,133 | $2.1M | 18.9% |
| 5 | $9.47 | 215,133 | $2.0M | 18.3% |
| 6 | $9.47 | 215,133 |
| $2.0M |
| 18.3% |
| Total | $9.64 avg | 1,151,892 | $11.1M | 100% |